Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06808048 · ClinicalTrials.gov registry record · NA
Medical Cannabis and Behavior
A NA study of Chronic Pain Patients and Medical Cannabis Users, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06808048 is a NA study of Chronic Pain Patients and Medical Cannabis Users that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 180 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06808048, a NA study of Chronic Pain Patients and Medical Cannabis Users, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess cognition, neural function, and drug exposure in chronic pain patients who have been prescribed medical cannabis and will differentiate outcomes based on use of specific CBD-dominant versus THC-dominant treatment products. This longitudinal study will recruit medical cannabis users from local dispensaries. Each participant will complete a baseline assessment prior to the start of medical cannabis use, monthly phone calls to assess treatment adherence, and a four-month follow- up assessment. The aims of this project are: Aim 1. To assess impacts of medical cannabis compounds on executive functions, learning and memory in adults to determine whether cognitive impairments are evident after the onset of cannabis use; Aim 2. To assess the impacts of medical cannabis compounds on white matter microstructure, functional brain activity and functional connectivity; Aim 3. To differentiate change over four months in these outcomes as a function of (a) age and (b) pre-to-post-treatment changes in blood levels of cannabinoid compounds.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive testing
- BEHAVIORAL Task-based fMRI measure of inhibitory control
- BEHAVIORAL Task-based fMRI measure of face-name learning
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-06-18 |
| Est. Completion | 2029-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06808048
The ClinicalTrials.gov registry entry for NCT06808048 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Pain Patients appearing as the primary indexed condition, and to 3 interventions - of which Cognitive testing is the first listed.
NCT06808048 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06808048 about?
NCT06808048 is a clinical study titled "Medical Cannabis and Behavior". This study will assess cognition, neural function, and drug exposure in chronic pain patients who have been prescribed medical cannabis and will differentiate outcomes based on use of specific CBD-dominant versus THC-dominant treatment products. This longitudinal study will recruit medical cannabis ...
What is the current status of trial NCT06808048?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-06-18. Estimated completion is 2029-07-31.
What conditions does trial NCT06808048 study?
This clinical trial studies the following conditions: Chronic Pain Patients, Medical Cannabis Users.
What interventions are being tested in trial NCT06808048?
The interventions under investigation include: Cognitive testing (BEHAVIORAL), Task-based fMRI measure of inhibitory control (BEHAVIORAL), Task-based fMRI measure of face-name learning (BEHAVIORAL).
Who is sponsoring clinical trial NCT06808048?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06808048 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.